Trading update and Acquisitions

RNS Number : 9327K
CVS Group plc
25 July 2011
 



Immediate Release

25 July 2011

 

 

CVS Group plc

 

Trading update and Acquisitions

 

The Board is pleased to announce that it expects results for the year ended 30 June 2011 to be in line with market expectations. Like for like turnover for the year showed growth in the region of +0.4%, with the second half delivering like for like sales growth in the region of +3%.

 

The Board is also pleased to report further acquisition activity in the second half of the financial year, with RH Campbell, Attimore and Clarendon House veterinary clinics being added to the Group's practice division. Net debt at 30 June was in line with market expectations, being in the region of £34 million, after having funded these acquisitions.

 

RH Campbell is a single site practice in Swansea acquired in January 2011. The turnover of the practice for the year ended 30 November 2010 was in the region of £0.3 million.

 

Attimore Veterinary Group is a five site practice in and around the Welwyn Garden City area acquired in April 2011. The turnover of the practice for the year ended 30 November 2010 was in the region of £1.3 million.

 

Clarendon House Veterinary Group is a three site practice in and around the Chelmsford area acquired in May 2011. The turnover of the practice for the year ended 30 September 2010 was in the region of £1.1 million.

 

All three acquisitions provide a good geographical fit with the Group's existing surgery locations.

 

In total the Group now operates 223 surgeries, 6 diagnostic laboratories, 1 pet crematorium and an online dispensary across the UK and remains the largest operator in a highly fragmented market.

 

The Board of Directors confirms that the preliminary results for the year ended 30 June 2011 will be announced on Tuesday 27 September 2011.

 

For further enquiries please contact:

 

CVS Group plc: 01379 644 288

Simon Innes - Chief Executive

Paul Coxon - Finance Director

 

Buchanan Communications: 020 7466 5000

Richard Oldworth

Christian Goodbody

 

Brewin Dolphin Investment Banking: 0845 059 6412

Nick Owen

Matt Davis


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFFEDEIFFIL

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings